Found 66 results

2009
Patel A.  2009.  Cardiovascular risk in Australians and Indians: lessons from comparative studies. 6th Indo-Australian Biotechnology Conference.
Patel A.  2009.  Impact of glucose control on macrovascular and microvascular disease: insights from ADVANCE. American Heart Association Scientific Sessions.
2008
ADVANCE Collaborative Group, (Writing Committee), Chalmers J, Joshi R, Kengne A-P, Ninomiya T, Bi Y, Bompoint S, Billot L, Patel A.  2008.  Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of evidence available in 2007 . J Hypertens . 26 :S21-S27.[IF4.364].
ADVANCE Collaborative Group, (Writing Committee), Patel A, MacMahon S, Chalmers J.  2008.  Intensive glucose control in type 2 diabetes . Reply. N Engl J Med. 359:1520-1.[IF52.589].
Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, Jardine M, Gallagher M, Turnbull F, Chalmers J et al..  2008.  The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med. 5:e207.[IF12.601].
Rodgers A, Patel A.  2008.  Why is there more heat than light concerning the polypill? Brit Med J. 337:a2162.[IF9.723].
Peiris D, Murray J, Scully D, Tilikawardene V, Hetaraka-Stevens L, Stewart T, Patel A.  2008.  Cardiovascular risk management at a Maori-led Primary Health Organisation - findings from a cross sectional audit. N Z Med J. 121:35-46.[IF0].
Gao R, Patel A, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Harris P et al..  2008.  Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart. 94 :554-60.[IF4.141].
ADVANCE Collaborative Group Writing Group, (Writing Committee), Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M et al..  2008.  Intensive blood glucose control on vascular outcomes in patients with type 2 diabetes . N Engl J Med . 358:2560-72.[IF52.589][Grant:ADVANCE&ProgramGrant].
ADVANCE Collaborative Group, (Writing Committee), Patel A, MacMahon S, Neal B, Billot L, Chalmers J.  2008.  The ADVANCE trial . Author.s reply. Lancet. 371:26.[IF28.638].
Ayer J, Almafragy H, Patel A, Hellyer R, Celermajer D.  2008.  Body mass index is an independent determinant of left atrial size. Heart, Lung & Circulation. 17:19-24.[IF1.043].
InterASIA Collaborative Group, (Writing Committee), Perkovic V, Cass A, Patel A, Suriyawongpaisal P, Barzi F, Chadban S, MacMahon S, Neal B.  2008.  High prevalence of chronic kidney disease in Thailand. Kidney Int. 73:473-9.[IF4.922].
Asia Pacific Cohort Studies Collaboration, (Writing Committee), Woodward M, Martiniuk A, Ying Lee CM, Lam TH, Vanderhoorn S, Ueshima H, Fang X, Kim HC et al..  2008.  Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region. Eur J Cardiovasc Prev Rehabil. 15:397-401.[IF2.221].
Chalmers J, Joshi R, Patel A.  2008.  ADVANCES in reducing the burden of vascular disease in type 2 diabetes. Clin Exp Pharmacol Physiol. 35:434-7.[IF2.038].
Stolk RP, van Schooneveld MJ, Cruickshank JK, Hughes AD, Stanton A, Lu J, Patel A, Thom SA, Grobbee DE, Vingerling JR et al..  2008.  Retinal vascular lesions in patients with type 2 diabetes mellitus of Caucasian and Asian origin . baseline results from the AdRem study . Diabetes Care. 31 :708-13.[IF7.851].
Chalmers J, [Booklet contributing authors], MacMahon S, Neal B, Patel A, Perkovic V, Kengne AP, Colagiuri S, Grobbee R, Hamet P et al..  2008.  New approaches for the prevention of vascular disease in Type 2 diabetes. :271-95.
Chalmers J, [Contributing authors], Colagiuri S, Cooper M, Grobbee R, Hamet P, Kengne A-P, MacMahon S, Marre M, Mogensen C-E et al..  2008.  Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III.
Chalmers J, contributing authors, Colagiuri S, Cooper M, Grobbee R, Hamet P, Kengne AP, MacMahon S, Marre M, Mogensen CE et al..  2008.  Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR. Issue III.
2007
Patel A, ADVANCE Collaborative Group, (Writing Committee), MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N et al..  2007.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet . 370:829-40.[IF28.638].
Asia Pacific Cohort Study Collaboration, (Writing Committee), Kengne AP, Patel A, Barzi F, Jamrozic K, Lam TH, Ueshima H, Ohkubo T, Kim HC et al..  2007.  Cholesterol, diabetes and major cardiovascular diseases in Asia Pacific region. Diabetologia. 50:2289-97.[ImpactFactor5.822].
Campbell D, Woodward M, Chalmers J, Colman S, Jenkins A, Kemp B, Neal B, Patel A, MacMahon S.  2007.  Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in subjects with cerebrovascular disease. J Hypertens . 25:699-705.[IF4.364].
Campbell D, Neal B, Chalmers J, Colman S, Jenkins A, Kemp B, Patel A, MacMahon S, Woodward M.  2007.  Low density lipoprotein particles and risk of intracerebral hemorrhage in subjects with cerebrovascular disease. Eur J Cardiovasc Prev Rehabil. 14:413-8.[IF2.221].
Chalmers J, Kengne AP, Joshi R, Perkovic V, Patel A.  2007.  New insights from ADVANCE. J Hypertens Suppl. 25:S23-30.
Monaghan H, Richens A, Colman S, Currie R, Girgis S, Jayne K, Neal B, Patel A.  2007.  A randomised trial of the effects of an intensive communication strategy on recruitment into a large-scale, multi-centre trial . Contemp Clin Trials. 28:1-5.[IF1.438].
Turnbull F, Patel A.  2007.  Acupuncture for blood pressure lowering.needling the truth. Editorial. Circulation. 115:3048-9[ImpactFactor12.755].

Latest news

Recently added pages

Our focus

George Institute sites